Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aprameya EngineeringNSE:APRAMEYA +6.79%42 EV-to-OCF is 7.94 as of Aug. 20, 2026. GuruFocus rates NSE:APRAMEYA with a GF Score™ of 42/100. The stock has 6 warning signs investors should review. Among 850 Medical Devices & Instruments companies, Aprameya Engineering ranks worse than 52.59% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Aprameya Engineering's Enterprise Value is ₹2,481.4 Mil.
Aprameya Engineering's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was ₹312.3 Mil. Therefore, Aprameya Engineering's EV-to-OCF for today is 7.94.
The historical rank and industry rank for Aprameya Engineering's EV-to-OCF or its related term are showing as below:
NSE:APRAMEYA'
s EV-to-OCF Range Over the Past 10 Years
Min: -59.23 Med: -24.97 Max: 14.64
Current: 8.75
During the past 7 years, the highest EV-to-OCF of Aprameya Engineering was 14.64. The lowest was -59.23. And the median was -24.97.
NSE:APRAMEYA's EV-to-OCF is ranked worse than 52.59% of 850
companies
in the Medical Devices & Instruments industry
Industry Median: 7.835
vs NSE:APRAMEYA: 8.75
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Aprameya Engineering's PE Ratio (TTM) for today is calculated as:
Aprameya Engineering's share price for today is ₹126.65.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aprameya Engineering's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹2.680.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Aprameya Engineering EV-to-OCF Related Terms
Aprameya Engineering EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Aprameya Engineering's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:APRAMEYA vs ISRG, BDX, MDLN: EV-to-OCF Comparison
For the Medical Instruments & Supplies subindustry, Aprameya Engineering's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aprameya Engineering EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aprameya Engineering's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Aprameya Engineering's EV-to-OCF falls into.
Aprameya Engineering's current Enterprise Value is ₹2,481.4 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aprameya Engineering's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was ₹312.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aprameya Engineering (NSE:APRAMEYA) has a EV-to-OCF of 7.94 as of Aug. 20, 2026. According to the industry distribution chart, Aprameya Engineering ranks #447 out of 850 companies in the Medical Devices & Instruments industry, placing it in the top 52.6%.
Is Aprameya Engineering's EV-to-OCF too high?
Aprameya Engineering's current EV-to-OCF is 7.94. The Medical Devices & Instruments industry median EV-to-OCF is 7.84. Aprameya Engineering's value of 7.94 is 1.3% above this industry median. Based on the distribution chart, Aprameya Engineering ranks #447 out of 850 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Aprameya Engineering has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Aprameya Engineering's EV-to-OCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Aprameya Engineering ranks #447 out of 850 companies for EV-to-OCF. This places Aprameya Engineering in the lower half of its industry. The industry median EV-to-OCF is 7.84. Aprameya Engineering's value of 7.94 is 1.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.84, based on 850 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aprameya Engineering's current EV-to-OCF of 7.94 is 1.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aprameya Engineering's current EV-to-OCF is 7.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprameya Engineering stock overvalued right now?
Aprameya Engineering (NSE:APRAMEYA) has a current EV-to-OCF of 7.94. The current EV-to-OCF is 7.94 and 1.3% above the Medical Devices & Instruments industry median of 7.84. Aprameya Engineering's overall GF Score™ is 42/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Aprameya Engineering (NSE:APRAMEYA), the current EV-to-OCF is 7.94 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aprameya Engineering Ltd is engaged in the business of installation, set up & maintenance of Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatre, dialysis centres and prefabricated structure ward (hereinafter referred to as Healthcare Infrastructure projects) in the hospitals and medical care centers on turnkey basis with the supply of high-value healthcare equipment and diagnostic equipment to private hospitals, Government hospitals, and medical practitioners. The company has two Business segments: Trading of Medical support Equipment (Trading Sales) and Supplies for Infra Projects for health care sectors (Turnkey project supplies). Key revenue is generated from Trunkey Project Supply.
42GF Score
Get the complete analysis for NSE:APRAMEYA
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:APRAMEYA has been successfully added to your 
